Entheon Biomedical Corp (ENBI.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in thousands)
| 11-2024 | 11-2023 | 11-2022 | 11-2021 | 11-2020 | |
| Sales | 0 | 250 | 190 | 22 | 0 |
| Cost of Goods | N/A | N/A | N/A | 13 | N/A |
| Gross Profit | 0 | N/A | N/A | 9 | N/A |
| Operating Expenses | 333 | 564 | 3,790 | 9,115 | 4,377 |
| Operating Income | -333 | -314 | -3,600 | -9,106 | -4,377 |
| Other Income | 15 | 14 | 1,539 | 220 | -5 |
| Pre-tax Income | -318 | -300 | -2,061 | -8,887 | -4,381 |
| Net Income Continuous | -318 | -300 | -2,061 | -8,887 | -4,381 |
| Net Income Discontinuous | N/A | 0 | -6,459 | N/A | N/A |
| Net Income | $-318 | $-300 | $-8,521 | $-8,887 | $-4,381 |
| EPS Basic Total Ops | -0.04 | -0.05 | -1.40 | -1.60 | -1.60 |
| EPS Basic Continuous Ops | -0.04 | -0.05 | -0.30 | -1.60 | -1.60 |
| EPS Basic Discontinuous Ops | N/A | 0.00 | -1.10 | N/A | N/A |
| EPS Diluted Total Ops | -0.04 | -0.05 | -1.40 | -1.60 | -1.60 |
| EPS Diluted Continuous Ops | -0.04 | -0.05 | -0.30 | -1.60 | -1.60 |
| EPS Diluted Discontinuous Ops | N/A | 0.00 | -1.10 | N/A | N/A |
| EBITDA(a) | $-333 | $-314 | $-3,598 | $-8,619 | $-4,379 |